Literature DB >> 12097586

Explant-induced reactivation of herpes simplex virus occurs in neurons expressing nuclear cdk2 and cdk4.

Luis M Schang1, Andrew Bantly, Priscilla A Schaffer.   

Abstract

Herpes simplex virus (HSV) establishes productive (lytic) infections in nonneuronal cells and nonproductive (latent) infections in neurons. It has been proposed that HSV establishes latency because quiescent neurons lack cellular factors required for productive infection. It has been further proposed that these putative factors are induced following neuronal stress, as a requirement for HSV reactivation. To date, the identity of these putative cellular factors remains unknown. We have demonstrated that cyclin-dependent kinase (cdk) 1, 2, or 7 is required for HSV replication in nonneuronal cells. Interestingly, cdks 1 and 2 are not expressed in quiescent neurons but can be induced in stressed neurons. Thus, cdks may be among the cellular proteins required for HSV reactivation whose neuronal expression is differentially regulated during stress. Herein, we determined that neuronal expression of nuclear cdk2, cdk4, and cyclins E and D2 (which activate cdks 2 and 4, respectively) was induced following explant cultivation, a stressful stimulus that induces HSV reactivation. In contrast, neuronal expression of cdk7 and cytoplasmic cdk4 decreased during explant cultivation, whereas cdk3 was detected in the same small percentage of neurons before and after explant cultivation and cdks 1, 5, and 6 were not detected in neuronal cell bodies. HSV-1 reactivated specifically in neurons expressing nuclear cdk2 and cdk4, and an inhibitor specific for cdk2 inhibited HSV-1 reactivation. We conclude that neuronal levels of cdk2 are among the factors that determine the outcome of HSV infections of neurons.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12097586      PMCID: PMC136347          DOI: 10.1128/jvi.76.15.7724-7735.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  74 in total

1.  Up-regulation of cyclin D1 occurs in apoptosis of immature but not mature cerebellar granule neurons in culture.

Authors:  K Sakai; K Suzuki; S Tanaka; T Koike
Journal:  J Neurosci Res       Date:  1999-11-01       Impact factor: 4.164

2.  Role of cell cycle regulatory proteins in cerebellar granule neuron apoptosis.

Authors:  J Padmanabhan; D S Park; L A Greene; M L Shelanski
Journal:  J Neurosci       Date:  1999-10-15       Impact factor: 6.167

3.  Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells.

Authors:  Y Matsumoto; K Hayashi; E Nishida
Journal:  Curr Biol       Date:  1999-04-22       Impact factor: 10.834

4.  Depolarization regulates cyclin D1 degradation and neuronal apoptosis: a hypothesis about the role of the ubiquitin/proteasome signalling pathway.

Authors:  A L Boutillier; P Kienlen-Campard; J P Loeffler
Journal:  Eur J Neurosci       Date:  1999-02       Impact factor: 3.386

5.  DNA fragmentation precedes aberrant expression of cell cycle-related protein in rat brain after MCA occlusion.

Authors:  T Hayashi; M Sakurai; K Abe; Y Itoyama
Journal:  Neurol Res       Date:  1999-10       Impact factor: 2.448

6.  pRb phosphorylation is regulated differentially by cyclin-dependent kinase (Cdk) 2 and Cdk4 in retinoic acid-induced neuronal differentiation of P19 cells.

Authors:  Y Watanabe; T Watanabe; M Kitagawa; Y Taya; K Nakayama; N Motoyama
Journal:  Brain Res       Date:  1999-09-25       Impact factor: 3.252

7.  Cyclin E-p27 opposition and regulation of the G1 phase of the cell cycle in the murine neocortical PVE: a quantitative analysis of mRNA in situ hybridization.

Authors:  I Delalle; T Takahashi; R S Nowakowski; L H Tsai; V S Caviness
Journal:  Cereb Cortex       Date:  1999-12       Impact factor: 5.357

8.  Increased cyclin D1 in vulnerable neurons in the hippocampus after ischaemia and epilepsy: a modulator of in vivo programmed cell death?

Authors:  S Timsit; S Rivera; P Ouaghi; F Guischard; E Tremblay; Y Ben-Ari; M Khrestchatisky
Journal:  Eur J Neurosci       Date:  1999-01       Impact factor: 3.386

9.  Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases.

Authors:  L M Schang; A Rosenberg; P A Schaffer
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  A novel strategy for inhibiting growth of human pancreatic cancer cells by blocking cyclin-dependent kinase activity.

Authors:  H Iseki; T C Ko; X Y Xue; A Seapan; C M Townsend
Journal:  J Gastrointest Surg       Date:  1998 Jan-Feb       Impact factor: 3.452

View more
  18 in total

1.  Comparison of herpes simplex virus reactivation in ganglia in vivo and in explants demonstrates quantitative and qualitative differences.

Authors:  N M Sawtell; R L Thompson
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

2.  Cyclin-dependent kinase 3-mediated activating transcription factor 1 phosphorylation enhances cell transformation.

Authors:  Duo Zheng; Yong-Yeon Cho; Andy T Y Lau; Jishuai Zhang; Wei-Ya Ma; Ann M Bode; Zigang Dong
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

3.  Role of a cdk5-associated protein, p35, in herpes simplex virus type 1 replication in vivo.

Authors:  Steve D Haenchen; Jeff A Utter; Adam M Bayless; Rick T Dobrowsky; David J Davido
Journal:  J Neurovirol       Date:  2010-10       Impact factor: 2.643

4.  Virus reactivation: a panoramic view in human infections.

Authors:  Christopher M Traylen; Hersh R Patel; Wylder Fondaw; Sheran Mahatme; John F Williams; Lia R Walker; Ossie F Dyson; Sergio Arce; Shaw M Akula
Journal:  Future Virol       Date:  2011-04       Impact factor: 1.831

Review 5.  Potential of protein kinase inhibitors for treating herpesvirus-associated disease.

Authors:  Renfeng Li; S Diane Hayward
Journal:  Trends Microbiol       Date:  2013-04-19       Impact factor: 17.079

6.  Pharmacological cyclin-dependent kinase inhibitors inhibit replication of wild-type and drug-resistant strains of herpes simplex virus and human immunodeficiency virus type 1 by targeting cellular, not viral, proteins.

Authors:  Luis M Schang; Andrew Bantly; Marie Knockaert; Farida Shaheen; Laurent Meijer; Michael H Malim; Nathanael S Gray; Priscilla A Schaffer
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

7.  Quantitative analysis of herpes simplex virus in cranial nerve ganglia.

Authors:  Jeffrey T Vrabec; Raye L Alford
Journal:  J Neurovirol       Date:  2004-08       Impact factor: 2.643

8.  Roscovitine, a cyclin-dependent kinase inhibitor, prevents replication of varicella-zoster virus.

Authors:  Shannon L Taylor; Paul R Kinchington; Andrew Brooks; Jennifer F Moffat
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

9.  Herpes simplex virus type 1 preferentially targets human colon carcinoma: role of extracellular matrix.

Authors:  Dror Kolodkin-Gal; Gideon Zamir; Yair Edden; Eli Pikarsky; Alon Pikarsky; Hillel Haim; Yosef S Haviv; Amos Panet
Journal:  J Virol       Date:  2007-10-31       Impact factor: 5.103

10.  Roscovitine inhibits activation of promoters in herpes simplex virus type 1 genomes independently of promoter-specific factors.

Authors:  Prerna Diwan; Jonathan J Lacasse; Luis M Schang
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.